{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:34:35Z","timestamp":1791855275013,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fayoum University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early detection and diagnosis of malignant tumors is critical for improving the survival rate and treatment outcomes of oral cancer. Thus, the current prospective investigation was designed to verify the role, sensitivity, and specificity of salivary LINC00657 and miRNA-106a as diagnostic markers in oral squamous cell carcinoma patients as compared to oral lichen planus (as an example of oral potentially malignant disorders) and normal individuals, and to show LINC00657 relation to miR-106a.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 36 participants were included, subdivided into 3 groups: Group I: 12 patients diagnosed with oral squamous cell carcinoma (OSCC). Group II: 12 patients diagnosed with oral lichen planus (OLP). Group III: 12 systemically free individuals with no oral mucosal lesions. Unstimulated salivary samples were collected from all participants to evaluate level of LINC00657 and miR-106a in different groups using quantitative real-time PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>OSCC showed the highest LINC00657 and lowest miR-106a fold change among included groups. Receiver Operating Characteristic (ROC) curve analysis of the two biomarkers for detecting OSCC revealed that LINC00657 had higher diagnostic accuracy (DA) (83.3%) compared to miR-106a (80.4%). As for detecting OLP, ROC analysis showed that miR-106a had higher (DA) (61%) compared to LINC00657 (52.5%). To discriminate OSCC from OLP, the diagnostic accuracy of both markers is the same (75%). Moreover, differentiating OSCC grades II and III, ROC analysis showed that miR-106a had lower (DA) (60%) compared to LINC00657 (DA) (83.3%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Salivary LINC00657 and miR-106a could be promising diagnostic markers for oral squamous cell carcinoma. Salivary LINC00657 may differentiate oral squamous cell carcinoma from oral potentially malignant disorders with considerable diagnostic accuracy. Moreover, low levels of salivary miR-106a could have the potential to indicate malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The study was retrospectively registered on clinicaltrial.gov with NCT05821179 (first trial registration in 26\/3\/2023), date of registration: 19\/4\/2023.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12903-023-03726-0","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T05:02:29Z","timestamp":1702357349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["\u201cSalivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study\u201d"],"prefix":"10.1186","volume":"23","author":[{"given":"Nayroz Abdel Fattah","family":"Tarrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfat Gamil","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"AbdelKawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"3726_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","volume":"45","author":"S Warnakulasuriya","year":"2009","unstructured":"Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45:309\u201316.","journal-title":"Oral Oncol."},{"issue":"2","key":"3726_CR2","first-page":"178","volume":"21","author":"P Tandon","year":"2017","unstructured":"Tandon P, Dadhich A, Saluja H, Bawane S, Sachdeva S. The prevalence of squamous cell carcinoma in different sites of oral cavity at our rural health Care Centre in Loni, Maharashtra - a retrospective 10-year study. Contemp Oncol (Pozn). 2017;21(2):178\u201383.","journal-title":"Contemp Oncol (Pozn)."},{"key":"3726_CR3","doi-asserted-by":"publisher","first-page":"104550","DOI":"10.1016\/j.oraloncology.2019.104550","volume":"102","author":"S Warnakulasuriya","year":"2020","unstructured":"Warnakulasuriya S. Oral potentially malignant disorders: a comprehensive review on clinical aspects and management. Oral Oncol. 2020;102:104550.","journal-title":"Oral Oncol"},{"issue":"8","key":"3726_CR4","first-page":"789","volume":"21","author":"NS Piyarathne","year":"2021","unstructured":"Piyarathne NS, Rasnayake RMSGK, Angammana R, Chandrasekera P, Ramachandra S, Weerasekera M, et al. Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors \u2013 a systematic review, expert rev. Mol Diagn. 2021;21(8):789\u2013807.","journal-title":"Mol Diagn."},{"key":"3726_CR5","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/j.jcpo.2013.04.002","volume":"1","author":"P Ford","year":"2013","unstructured":"Ford P, Farah C. Early detection and diagnosis of oral cancer: strategies for improvement. J Cancer Policy. 2013;1:e2\u20137.","journal-title":"J Cancer Policy."},{"key":"3726_CR6","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/cncr.32583","volume":"126","author":"A Thompson-Harvey","year":"2020","unstructured":"Thompson-Harvey A, Yetukuri M, Hansen AR, Simpson MC, Adjei Boakye E, Varvares MA, et al. Rising incidence of late-stage head and neck cancer in the United States. Cancer. 2020;126:1090\u2013101.","journal-title":"Cancer."},{"issue":"Suppl. 1","key":"3726_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1834-7819.2010.01200.x","volume":"55","author":"M McCullough","year":"2010","unstructured":"McCullough M, Prasad G, Farah C. Oral mucosal malignancy and potentially malignant lesions: an update on the epidemiology, risk factors, diagnosis, and management. Aust Dent J. 2010;55(Suppl. 1):61\u20135.","journal-title":"Aust Dent J."},{"issue":"19","key":"3726_CR8","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.3889\/oamjms.2019.689","volume":"7","author":"S Minhas","year":"2019","unstructured":"Minhas S, Sajjad A, Kashif M, Taj F, Waddani HA, Khurshid Z. Oral ulcers presentation in systemic diseases: an update. Open Access Maced J Med Sci. 2019;7(19):3341\u20137.","journal-title":"Open Access Maced J Med Sci."},{"key":"3726_CR9","doi-asserted-by":"publisher","first-page":"598817","DOI":"10.3389\/fonc.2020.598817","volume":"10","author":"N Gao","year":"2020","unstructured":"Gao N, Li Y, Li J, Gao Z, Yang Z, Li Y, et al. Long non-coding RNAs: the regulatory mechanisms, research strategies, and future directions in cancers. Front Oncol. 2020;10:598817.","journal-title":"Front Oncol."},{"issue":"2","key":"3726_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9.","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"6","key":"3726_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s13402-018-0406-4","volume":"41","author":"R Castro-Oropeza","year":"2018","unstructured":"Castro-Oropeza R, Melendez-Zajgla J, Maldonado V, Vazquez-Santillan K. The emerging role of lncRNAs in the regulation of Cancer stem cells. Cell Oncol. 2018;41(6):585\u2013603. https:\/\/doi.org\/10.1007\/s13402-018-0406-4.","journal-title":"Cell Oncol."},{"key":"3726_CR12","doi-asserted-by":"publisher","first-page":"714787","DOI":"10.3389\/fcell.2021.714787","volume":"9","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Azimi T, Hussen BM, Abak A, Taheri M, Dilmaghani NA. Non-coding RNA activated by DNA damage: review of its roles in the carcinogenesis. Front Cell Dev Biol. 2021;9:714787.","journal-title":"Front Cell Dev Biol."},{"key":"3726_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-019-0781-6","volume":"19","author":"K Zhou","year":"2019","unstructured":"Zhou K, Ou Q, Wang G, Zhang W, Hao Y, Li W. High long non-coding RNA NORAD expression predicts poor prognosis and promotes breast cancer progression by regulating TGF-b pathway. Cancer Cell Int. 2019;19:1\u20137.","journal-title":"Cancer Cell Int."},{"key":"3726_CR14","first-page":"3760","volume":"23","author":"S Yu","year":"2019","unstructured":"Yu S, et al. Silencing the long noncoding RNA NORAD inhibits gastric cancer cell proliferation and invasion by the RhoA\/ROCK1 pathway. Eur Rev Med Pharmacol Sci. 2019;23:3760\u201370.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"3726_CR15","doi-asserted-by":"publisher","first-page":"12051","DOI":"10.1002\/jcp.27869","volume":"234","author":"X Yang","year":"2019","unstructured":"Yang X, Cai JB, Peng R, Wei CY, Lu JC, Gao C, et al. The long noncoding RNA NORAD enhances the TGF-b pathway to promote hepatocellular carcinoma progression by targeting miR-202-5p. J Cell Physiol. 2019;234:12051\u201360.","journal-title":"J Cell Physiol."},{"issue":"1","key":"3726_CR16","doi-asserted-by":"publisher","first-page":"BSR20193489","DOI":"10.1042\/BSR20193489","volume":"40","author":"Q Huang","year":"2020","unstructured":"Huang Q, Xing S, Peng A, Yu Z. NORAD accelerates chemoresistance of non-small-cell lung cancer via targeting at miR-129-1 3p\/SOX4 axis. Biosci Rep. 2020;40(1):BSR20193489.","journal-title":"Biosci Rep."},{"key":"3726_CR17","first-page":"2482","volume":"24","author":"F Xu","year":"2020","unstructured":"Xu F, Xu X, Hu X. LINC00657 promotes malignant progression of oral squamous cell carcinoma via regulating microRNA-150. Eur Rev Med Pharmacol Sci. 2020;24:2482\u201390.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"3726_CR18","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1126\/science.1065329","volume":"294","author":"RC Lee","year":"2001","unstructured":"Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science. 2001;294:862\u20134.","journal-title":"Science."},{"key":"3726_CR19","first-page":"17559","volume":"6","author":"Z Li","year":"2015","unstructured":"Li Z, Yu X, Wang Y, Shen J, Wu WK, Liang J, et al. By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth. Onco Target. 2015a;6:17559\u201369.","journal-title":"Onco Target."},{"key":"3726_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10120-014-0340-8","volume":"18","author":"Z Li","year":"2015","unstructured":"Li Z, Lei H, Luo M, Wang Y, Dong L, Ma Y, et al. DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer. 2015b;18:43\u201354.","journal-title":"Gastric Cancer."},{"key":"3726_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jcmm.12649","volume":"20","author":"X Yu","year":"2016","unstructured":"Yu X, Li Z. The role of miRNAs in cutaneous squamous cell carcinoma. J Cell Mol Med. 2016;20:3\u20139.","journal-title":"J Cell Mol Med."},{"key":"3726_CR22","doi-asserted-by":"publisher","first-page":"e3155","DOI":"10.1038\/cddis.2017.561","volume":"8","author":"YJ Pan","year":"2017","unstructured":"Pan YJ, Wei LL, Wu XJ, Huo FC, Mou J, Pei DS. MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5. Cell Death Dis. 2017;8:e3155.","journal-title":"Cell Death Dis."},{"key":"3726_CR23","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.3892\/or.2016.5015","volume":"36","author":"SS Shin","year":"2016","unstructured":"Shin SS, Park SS, Hwang B, Kim WT, Choi YH, Kim WJ, et al. MicroRNA-106a suppresses proliferation, migration, and invasion of bladder cancer cells by modulating MAPK signaling cell cycle regulators, and Ets-1-mediated MMP-2 expression. Oncol Rep. 2016;36:2421\u20139.","journal-title":"Oncol Rep."},{"key":"3726_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-018-0127-8","volume":"24","author":"B Shi","year":"2019","unstructured":"Shi B, Ma C, Liu G, Guo Y. MiR-106a directly targets LIMK1 to inhibit proliferation and EMT of oral carcinoma cells. Cell Mol Biol Lett. 2019;24:1.","journal-title":"Cell Mol Biol Lett."},{"key":"3726_CR25","first-page":"105","volume-title":"WHO classification of head and neck tumours","author":"AK El-Naggar","year":"2017","unstructured":"El-Naggar AK, Chan J, Grandis J, Takata T, Slootweg P. WHO classification of head and neck tumours. 4th ed; 2017. p. 105\u201311.","edition":"4"},{"key":"3726_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0030-4220(68)90194-1","volume":"25","author":"JO Andreasen","year":"1968","unstructured":"Andreasen JO. Oral lichen planus. 1. A clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol. 1968;25:31\u201342. https:\/\/doi.org\/10.1016\/0030-4220(68)90194-1.","journal-title":"Oral Surg Oral Med Oral Pathol."},{"key":"3726_CR27","volume-title":"In Comprehensive Cervical Cancer Control: A Guide to Essential Practice","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Cancer and pre-cancer classification systems, Annex 4. In: In Comprehensive Cervical Cancer Control: A Guide to Essential Practice. 2nd ed. World Health Organization; 2014.","edition":"2"},{"key":"3726_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13005-015-0063-z","volume":"11","author":"E Omar","year":"2015","unstructured":"Omar E. Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma\u2014a systematic review. Head Face Med. 2015;11:6.","journal-title":"Head Face Med."},{"key":"3726_CR29","first-page":"519","volume":"58","author":"M Carrozzo","year":"2009","unstructured":"Carrozzo M, Thorpe R. Oral lichen planus: a review. Minerva Stomatol. 2009;58:519\u201337.","journal-title":"Minerva Stomatol."},{"key":"3726_CR30","first-page":"40","volume-title":"Histological methods and type of biopsy. Biopsy pathology and cytology of the cervix","year":"1999","unstructured":"Colema DV, Evans DM, Baker R, editors. Histological methods and type of biopsy. Biopsy pathology and cytology of the cervix. 2nd ed. London: Arnold Company; 1999. p. 40.","edition":"2"},{"key":"3726_CR31","first-page":"17","volume-title":"CV","author":"DA Kerr","year":"1965","unstructured":"Kerr DA, Millard HD. Oral Diagnosis. In: CV. 2nd ed. Saint-Louis: Mosby Company; 1965. p. 17.","edition":"2"},{"key":"3726_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1749-6632.1993.tb18343.x","volume":"694","author":"M Navazesh","year":"1993","unstructured":"Navazesh M. Methods for collecting saliva. Ann N.Y. Acad Sci. 1993;694:72\u20137.","journal-title":"Acad Sci."},{"key":"3726_CR33","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/iub.2039","volume":"71:(9)","author":"OG Shaker","year":"2019","unstructured":"Shaker OG, Ali MA, Ahmed TI, Zaki OM, Ali DY, Hassan EA, et al. Association between LINC00657 and miR-106a serum expression levels and susceptibility to colorectal Cancer, adenomatous polyposis, and ulcerative colitis in Egyptian population. IUBMB Life. 2019;71:(9):1322\u201335.","journal-title":"IUBMB Life."},{"key":"3726_CR34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4103\/0976-237X.194108","volume":"7","author":"V Chaudhari","year":"2016","unstructured":"Chaudhari V, Pradeep GL, Prakash N, Mahajan AM. Estimation of salivary sialic acid in oral premalignancy and oral squamous cell carcinoma. Contemp Clin Dent. 2016;7:451\u20136.","journal-title":"Contemp Clin Dent."},{"key":"3726_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.4103\/jcrt.JCRT_512_19","volume":"16","author":"VD Guruaribam","year":"2020","unstructured":"Guruaribam VD, Sarumathi T. Relevance of serum and salivary sialic acid in oral cancer diagnostics. J Can Res Ther. 2020;16:401\u20134.","journal-title":"J Can Res Ther."},{"key":"3726_CR36","first-page":"241","volume":"22","author":"YH Lee","year":"2009","unstructured":"Lee YH, Wong DT. Saliva: an emerging biofluid for early detection of diseases. Am J Dent. 2009;22:241\u20138.","journal-title":"Am J Dent."},{"key":"3726_CR37","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1042\/BCJ20170079","volume":"474","author":"O Slaby","year":"2017","unstructured":"Slaby O, Laga R, Sedlacek O. Therapeutic targeting of non-coding RNAs in cancer. Biochem J. 2017;474:4219\u201351.","journal-title":"Biochem J."},{"key":"3726_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18:5\u201318.","journal-title":"Nat Rev Cancer."},{"key":"3726_CR39","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1021\/acs.jafc.9b01667","volume":"67","author":"M Wang","year":"2019","unstructured":"Wang M, Jiang S, Yu F, Zhou L, Wang K. Noncoding RNAs as molecular targets of resveratrol underlying its anticancer effects. J Agric Food Chem. 2019;67:4709\u201319.","journal-title":"J Agric Food Chem."},{"key":"3726_CR40","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1126\/science.1140735","volume":"319","author":"TD Halazonetis","year":"2008","unstructured":"Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene induced DNA damage model for cancer development. Science. 2008;319:1352\u20135.","journal-title":"Science."},{"key":"3726_CR41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cell.2015.12.017","volume":"164","author":"S Lee","year":"2016","unstructured":"Lee S, Kopp F, Chang TC, Sataluri A, Chen B, Sivakumar S, et al. Noncoding RNA NORAD regulates genomic stability by sequestering PUMILIO proteins. Cell. 2016;164:69\u201380.","journal-title":"Cell."},{"key":"3726_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ebiom.2018.06.026","volume":"33","author":"Z Xie","year":"2018","unstructured":"Xie Z, Zhou F, Yang Y, Li L, Lei Y, Lin X, et al. Lnc-PCDH9-13:1 is a hypersensitive and specific biomarker for early hepatocellular carcinoma. EBioMedicine. 2018;33:57\u201367.","journal-title":"EBioMedicine."},{"key":"3726_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biocel.2017.09.008","volume":"92","author":"B Hu","year":"2017","unstructured":"Hu B, Cai H, Zheng R, Yang S, Zhou Z, Tu J. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression. Int J Biochem Cell Biol. 2017;92:34\u201342.","journal-title":"Int J Biochem Cell Biol."},{"key":"3726_CR44","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.biopha.2018.09.003","volume":"108","author":"Y Sun","year":"2018","unstructured":"Sun Y, Wang J, Pan S, Yang T, Sun X, Wang Y, et al. LINC00657 played oncogenic roles in esophageal squamous cell carcinoma by targeting miR-615-3p and JunB. Biomed Pharmacother. 2018;108:316\u201324.","journal-title":"Biomed Pharmacother."},{"key":"3726_CR45","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/15384101.2020.1731645","volume":"19","author":"S Bi","year":"2020","unstructured":"Bi S, Wang Y, Feng H, Li Q. Long noncoding RNA LINC00657 enhances the malignancy of pancreatic ductal adenocarcinoma by acting as a competing endogenous RNA on microRNA-433 to increase PAK4 expression. Cell Cycle. 2020;19:801\u201316.","journal-title":"Cell Cycle."},{"issue":"4","key":"3726_CR46","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5624\/isd.2018.48.4.233","volume":"48","author":"AF Farag","year":"2018","unstructured":"Farag AF, Abou-Alnour DA, Abu-Taleb NS. Oral carcinoma cuniculatum, an unacquainted variant of oral squamous cell carcinoma: a systematic review. Imaging Sci Dent. 2018;48(4):233\u201344.","journal-title":"Imaging Sci Dent."}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-03726-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-023-03726-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-03726-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T06:04:00Z","timestamp":1702361040000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-023-03726-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3726"],"URL":"https:\/\/doi.org\/10.1186\/s12903-023-03726-0","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"22 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the research ethics committee of faculty of Dentistry Beni-Suef university (Approval number: # REC-FDBSU\/06102022\u201303\/AM), following the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All included individuals in this study signed written consent after clarifying to them the steps and aim of the study. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"994"}}